MX2008003422A - Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof. - Google Patents

Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof.

Info

Publication number
MX2008003422A
MX2008003422A MX2008003422A MX2008003422A MX2008003422A MX 2008003422 A MX2008003422 A MX 2008003422A MX 2008003422 A MX2008003422 A MX 2008003422A MX 2008003422 A MX2008003422 A MX 2008003422A MX 2008003422 A MX2008003422 A MX 2008003422A
Authority
MX
Mexico
Prior art keywords
composition
acid derivative
naphthoic acid
derivatives
compound
Prior art date
Application number
MX2008003422A
Other languages
Spanish (es)
Inventor
Claire Mallard
Eve Ferrara
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0509493A external-priority patent/FR2890861B1/en
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2008003422A publication Critical patent/MX2008003422A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a composition for topical application comprising, in a physiologically acceptable medium, at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof . The invention is characterized in that the said naphthoic acid derivative is in a form dispersed in the said composition. The invention applies in particular to human pharmacy or cosmetics.
MX2008003422A 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof. MX2008003422A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0509493A FR2890861B1 (en) 2005-09-16 2005-09-16 COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOTIC ACID DERIVATIVE AND AT LEAST ONE POLYURETHANE POLYMER TYPE COMPOUND OR DERIVATIVES THEREOF, PROCESS FOR PREPARING THE SAME, AND USE THEREOF
US72527905P 2005-10-12 2005-10-12
PCT/IB2006/003852 WO2007031883A2 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof

Publications (1)

Publication Number Publication Date
MX2008003422A true MX2008003422A (en) 2008-03-27

Family

ID=37865321

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008003422A MX2008003422A (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof.

Country Status (7)

Country Link
EP (1) EP1933827A2 (en)
JP (2) JP5074401B2 (en)
AU (1) AU2006290364B2 (en)
CA (1) CA2622468A1 (en)
MX (1) MX2008003422A (en)
RU (1) RU2421216C2 (en)
WO (1) WO2007031883A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2916975B1 (en) * 2007-06-11 2009-09-04 Galderma Res & Dev COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE, AND USES THEREOF
FR2916966B1 (en) * 2007-06-11 2011-01-14 Galderma Res & Dev COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE, AND USES THEREOF
CA2693061A1 (en) * 2007-07-06 2009-01-15 Galderma Research & Development Compositions for topical application for the treatment of keratinization disorders
EP2065032A1 (en) * 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
CN103142460B (en) * 2007-11-30 2016-08-31 盖尔德马研究及发展公司 Composition containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film forming agent, their preparation method and its usage
MX337166B (en) 2009-06-24 2016-02-15 Topical composition containing ibuprofen.
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
JP5521190B2 (en) * 2009-10-01 2014-06-11 国立大学法人東京工業大学 Collagen composition and method for producing the same
CA2796412A1 (en) * 2010-04-29 2011-11-03 Galderma Research & Development Method for treating scars with adapalene 0.3%
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
ES2700148T3 (en) * 2012-03-09 2019-02-14 Covestro Deutschland Ag Aqueous polyurethane dispersion for the treatment of acne
JPWO2019240290A1 (en) * 2018-06-16 2021-06-24 ロート製薬株式会社 Topical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299758B1 (en) * 1987-07-16 1994-12-14 The Regents Of The University Of California Compositions for enhancing the cutaneous penetration of pharmacologically active agents
JPH061851A (en) * 1992-06-19 1994-01-11 Toyo Ink Mfg Co Ltd Pigment composition and aqueous pigment dispersion
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders

Also Published As

Publication number Publication date
AU2006290364A1 (en) 2007-03-22
JP2009508843A (en) 2009-03-05
RU2421216C2 (en) 2011-06-20
WO2007031883A3 (en) 2007-09-13
EP1933827A2 (en) 2008-06-25
AU2006290364B2 (en) 2012-07-05
JP5074401B2 (en) 2012-11-14
JP2012184258A (en) 2012-09-27
WO2007031883A2 (en) 2007-03-22
CA2622468A1 (en) 2007-03-22
RU2008114840A (en) 2009-10-27

Similar Documents

Publication Publication Date Title
MX2008003422A (en) Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof.
MX2010005516A (en) Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof.
MX2009005308A (en) Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use.
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2006099941A8 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
TW200744661A (en) Topical cosmetic formulations for regulating and improving the moisture content of the skin
WO2011148328A3 (en) Cosmetic process for making-up and/or caring for the skin and/or the lips
WO2008139122A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
WO2010072958A3 (en) Topical pharmaceutical composition containing a water-sensitive active principle
WO2008037380A3 (en) Alkyl benzoate mixtures
WO2007132134A3 (en) Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
WO2008139123A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
BRPI0617045B8 (en) composition, process for preparing a composition, use of a composition and cosmetic use of a composition
PL1893237T3 (en) Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle
PL1868631T3 (en) Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
WO2007077318A3 (en) Use of a peptidic rice extract as an active agent inducing the synthesis of sirt proteins in skin cells
MX2009003060A (en) Emulsion.
WO2008050157A3 (en) Ozonated oil formulations
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
WO2007003773A3 (en) Use of a yeast extract in the form of an active agent for inducing a synthesis of sirt proteins in skin cells
WO2009007622A3 (en) Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof
WO2007138233A3 (en) Use of zatosetron for the treatment of rosacea, and pharmaceutical compositions
WO2009156677A3 (en) Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative

Legal Events

Date Code Title Description
FG Grant or registration